An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears-Reference-Cited by-同舟云学术

An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears

Published:2009-07 Issue:4 Volume:16 Page:765-769
ISSN:1072-3714
Container-title:Menopause
language:en
Short-container-title:

Author:

Bateson Deborah J.,Weisberg Edith

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference13 articles.

1. Can we really beat cervical cancer?;Garland;Med J Aust,2003

2. The influence of the cervix on smear quality. I: atrophy. An audit of cervical smears taken post-colposcopic management of intraepithelial neoplasia.;Waddell;Cytopathology,1997

3. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.;Gupta;Diagn Cytopathol,2006

4. Squamous atypia in the atrophic cervical vaginal smear.;Abati;Cancer Cytopathol,1998

5. The significance of atypical cervical cytology in an older population.;Kaminski;Obstet Gynecol,1989

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Cervical Cancer Screening in Transgender Men: What Are the Particularities of This Approach?;Transgender Health;2024-06-13

2. Diagnosis of Cervical Intraepithelial Neoplasia with Special Reference to Roles of Cervical Cytology and Colposcopy;Comprehensive Gynecology and Obstetrics;2024

3. Factors Associated with Unsatisfactory Pap Tests Among Sexually Active Trans Masculine Adults;LGBT Health;2023-05-01

4. Non-procreative Reproductive Issues and Sexual Function in Transmasculine Individuals;Reproduction in Transgender and Nonbinary Individuals;2023

5. Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study;Cancer Communications;2022-02-10